Condition
Chronic Wounds
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 10 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
10 shownMiro3D Wound Matrix for Treatment of Diabetic Foot UlcersNCT07632001 · 2026-06-15
RECRUITINGTHERAVEX Tissue Care Spray Plus for the Management of Cutaneous Wounds, Burns, and Chronic UlcersNCT07617961 · 2025-10-02
RECRUITINGDiabetic Foot Ulcer (DFU) Biofilm Infection and RecurrenceNCT05172089 · 2024-04-02
RECRUITINGStudy of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient CareNCT06939673 · 2024-02-29
RECRUITINGSubcutaneous Dexpanthenol Administration and Wound EpithelializationNCT07395674 · 2026-08-02
NOT_YET_RECRUITINGEfficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic WoundsNCT07223892 · 2026-01-01
NOT_YET_RECRUITINGEvaluation of Cold Plasma in Chronic Wound HealingNCT06964048 · 2025-06-01
NOT_YET_RECRUITINGAbsorption and Safety of Topical Timolol to Treat Chronic WoundsNCT04903366 · 2017-11-21
COMPLETEDSwab Sample Collection for the Detection of Bacterial ProteasesNCT01881815 · 2013-06-01
COMPLETEDFGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis UlcersNCT00425178 · 2005-09-02
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
RECRUITING4
COMPLETED3
NOT_YET_RECRUITING3
Phase mix
NA4
PHASE11
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.